Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones

Figure 4

Mechanism of action of PPARγ when it is activated by its exogenous ligands thiazolidinediones (TZDs).